CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6 (disorder)
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6 (disorder)
|
|
0.800 |
GeneticVariation
|
UNIPROT |
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.
|
25356965 |
2015 |
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6 (disorder)
|
|
0.800 |
GeneticVariation
|
UNIPROT |
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).
|
25173338 |
2014 |
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6 (disorder)
|
|
0.800 |
GeneticVariation
|
UNIPROT |
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
|
23788249 |
2013 |
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6 (disorder)
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Clinical utility gene card for: hypertrophic cardiomyopathy (type 1-14).
|
21267010 |
2011 |
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6 (disorder)
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
|
11827995 |
2002 |
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6 (disorder)
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.
|
11371514 |
2001 |
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6 (disorder)
|
|
0.800 |
CausalMutation
|
CLINVAR |
|
|
|
Cardiomyopathies
|
|
0.010 |
GeneticVariation
|
BEFREE |
PRKAG2 cardiomyopathy is recapitulated in transgenic mice overexpressing mutant PRKAG2 N488I in the heart (TGgamma2N488I).
|
16275868 |
2005 |
Hypertrophic Cardiomyopathy
|
|
0.010 |
GeneticVariation
|
BEFREE |
Although the cardiac pathology caused by PRKAG2 mutations Arg302Gln, Thr400Asn, and Asn488Ile include myocyte enlargement and minimal interstitial fibrosis, these mutations were not associated with myocyte and myofibrillar disarray, the pathognomonic features of hypertrophic cardiomyopathy caused by sarcomere protein mutations.
|
11827995 |
2002 |
Hypertrophic obstructive cardiomyopathy
|
|
0.010 |
GeneticVariation
|
BEFREE |
Although the cardiac pathology caused by PRKAG2 mutations Arg302Gln, Thr400Asn, and Asn488Ile include myocyte enlargement and minimal interstitial fibrosis, these mutations were not associated with myocyte and myofibrillar disarray, the pathognomonic features of hypertrophic cardiomyopathy caused by sarcomere protein mutations.
|
11827995 |
2002 |